Kl

[The Practical Diabetic (Leon Tribe) @PracticalDeeb]

@WilmotEmma confirms the @dexcom alerts are often all turned off. Maybe if they are being turned off, they are failing to alert and are just being seen as annoying. Ergonomic design and user feedback might help. #ATTD2023 #dedoc

[Tim Street @Tims_Pants]

Dexcom @typezerotech discussing "Project Liberty" Fully closed loop.

Sounds suspiciously similar to the efforts of the #WeAreNotWaiting community, even down to using Time Above Range to factor into how aggressive the algorithm should be (@mathieutelier).

#ATTD2023
#ATTD23

[Mary Murphy @loopingntheloup]

Hamidah highlights to us all how unequal care for #t1d in Africa is. HCPs are hours away. Power can't be depended on. Needs devices compatible w living situations, basic phones. Focus on social challenges- poverty (access to food) & education. #dedocvoices @dedocORG #ATTD2023

[@carogomezmartin @carogomezmartin]

News from #CGM metrics for Trials:

👉🏻New Time in “tight” range 70-140 mg/dl
👉🏻Prolonged Hypo >120 min
👉🏻 A difference of ≥5% in TIR is clinically meaningful for an individual participant and 3% is clinically meaningful for a treatment group

@TBattelino @ATTDconf #ATTD2023

[Emma Wilmot @WilmotEmma]

Half of those diagnosed with T1DM are diagnosed over the age of 18 #ATTD2023

[Tidepool @Tidepool_org]

We did it!!!

Groundbreaking news: Tidepool Loop receives FDA Clearance!

This is the first ever fully interoperable automated insulin dosing app, cleared by the FDA that began as a patient-led initiative. Find the inside scoop here: https://t.co/E4Z15pYjfZ

[Michael Albert, MD @MichaelAlbertMD]

🚨Metabolic-bariatric surgery has demonstrated benefit as a bridge to organ transplant for...
➡️ESRD
➡️cirrhosis
➡️HFrEF
...via earlier candidacy listing and higher probability of survival to transplantation.
https://t.co/RN5XAEnTuo

[Giuseppe Maltese @docmaltese]

People living with diabetes should not be referred to as “diabetics” or described as “noncompliant” or blamed for their health condition. (ADA/EASD 2022 consensus ).

#LanguageMatters #EASD2022

[Dr. Alice Cheng @AliceYYCheng]

This concept is one of my favorite changes to EASD/ADA consensus. Recognition of the “little things” that make such a difference. #EASD2022

[Alicia Yepez @YepezDra]

Dr. Boulé: Fasted vs fed exercise seems better, with a bit different response in T2D #EASD2022

[Ines Jakopanec @ineska_neka]

Interesting research about definition for body size categories from childhood 👧🏼 ▶️ to adulthood 👩🏼

#EASD2022 #dedoc

[Alicia Yepez @YepezDra]

Very interesting data about the insulin resistant brain, body fat distribution and cognitive function (and restore function with exercise and empagliflozin) Dr Martin Heni. #EASD2022

[Diabetes UK Research @DUK_research]

Cracking presentation by Dr Simon Brackley highlighting how psychological & physical wellbeing after a #diabetes diagnosis can be intertwined

⬆️ psychological resilience at T1D diagnosis prospectively linked to ⬇️ HbA1c 2 yrs later

No relationship in T2D

#EASD2022 @angusgjones

[Sufyan Hussain @sugarydoc]

Reducing waste + recycling for diabetes tech

Glad im not alone in thinking on these lines.....

#gbdoc @DTN_UK

[Teresa Maria Linpin @Teyma712]

Excercise to improve insuline resistance.
HIIT to treat #diabetes

Really interesting!

#EASD2022
@EASDnews

[Nemencio A. Nicodemus Jr @DokNemie]

High intensity interval training (cycling and rowing) improves insulin sensitivity of people with obesity and diabetes to levels which are almost similar to lean men without diabetes - Petersen #EASD2022

[Mark Evans @MEvansCambridge]

8.5h more time in range with fully closed loop - jaw dropping!!!

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

Results:

14% improvement TIR (p<0.001) as mean adjusted treatment affect.

AID improved TIR: 61.2 ± 12.3% to 71.2 ± 12.1%

(Control arm TIR: 57.7 ± 14.3% to 54.5 ± 16.0%)

No treatment effect by age interaction was detected (p=0.56)

8/ #ADA2022

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

AID improved TIR for both kids and adults overall, but was most effective at night for both groups.

This graph shows the DIFFERENCE in percentage of TIR, so you can see the bigger difference at night vs day and overall.

9/ #ADA2022

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

📣 Presentation of the primary outcome results from the CREATE Trial, which assessed open source automated insulin delivery (AID) compared to sensor-augmented pump therapy (SAPT) in adults & kids with T1D, at #ADA2022!

@DrMartindeBock1 presenting on behalf of CREATE team.

1/